Artificial intelligence (AI) has the potential to significantly improve healthcare by providing
individualized therapies and improving diagnostic accuracy when integrated with medical
devices. This study investigates the application of artificial intelligence (AI) in medical
devices, with a particular emphasis on the FDA's creative techniques and regulatory
considerations. In order to assure safety and efficacy, the FDA's regulatory framework
classifies AI-based medical devices into Class I, II, and III based on risk, using procedures
including 510(k) clearance, premarket approval (PMA), and the De Novo pathway. The notion
of Software as a Medical Device (SAMD) underscores the significance of regulatory
supervision in the context of AI-powered applications. The many uses of AI in healthcare are
demonstrated by AI-based products, such as clinical decision support systems, wearable health
monitors, and diagnostic imaging tools. Given the adaptive nature of AI algorithms and
potential biases in the algorithms, the FDA places a strong emphasis on post-market
surveillance to address continuing safety and efficacy. By assessing the developer's procedures
rather than the product itself, cutting-edge FDA programs like the Digital Health Software
Precertification. Program seek to expedite the approval process. In order to standardize
standards and guarantee that AI devices created elsewhere may satisfy American regulations,
the FDA also promotes cooperation with industry participants, medical professionals, andinternational regulatory organizations. These initiatives strive to strike a compromise between
the strict patient safety regulations and the need for innovation, encouraging the creation of AI-
integrated medical devices that improve healthcare while upholding high safety requirements
Keywords: Artificial Intelligence (AI), Healthcare, Individualized therapies, Diagnostic
accuracy, Medical devices, FDA (Food and Drug Administration), Regulatory
considerations, 510(k) clearance, Class I, II, III (risk classification), Software as a
Medical Device (SAMD)
Publication date: 01/11/2025
https://ijbpas.com/pdf/2025/November/MS_IJBPAS_2025_9582.pdf
Download PDF
https://doi.org/10.31032/IJBPAS/2025/14.11.9582
